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Effects of temperature and concentration
on the adsorption of hCG to polystyrene
beads. Alkaline phosphatase anti-beta-
hCG conjugated antibody was used to detect
bound hCG. The substrate used was p-
nitrophenol phosphate. The reaction was
stopped by the addition of 2.0 ml of 0.2M
EDTA and absorbance readings were made at
405 nm. Each point represents the average
of three absorbance values. Incubation
temperatures were 3 C (A), 25 C (0) and
37 C (0) .18
Figure 2. Percentage of hCG bound to polystyrene
beads as a function of initial concentration.
Several runs are shown. (0) represents ini-
tial concentrations of 2-412 mIU/m1 hCG.
(0) are beads which were run in duplicate.
(A) denotes binding of hCG to polypropylene
tube 21
Figure 3. Binding linearity as a function of initial
hCG concentration. Exclusion of the outlying
point gives the regression line shown. mIU
hCG bound was equal to 0.327 (mIU hCG added),
r= 0.997. 23
Figure 4. Derivation of K and Ab. OX is the slope
tangent to the curve at 0 mIU binding.
(--) denotes the plateau or maximum binding.
Ab refers to the total binding capacity of
the bead. Curve is actual binding data. If
Li is defined as the hCG concentration where
the line OX crosses Ab and the point at
which OX crosses 0.5 Ab as L2, then K may be
determined as 1/(2(L2)-L1) and Ab may be
calculated as Ab=2(L1)-2(L2). K is the
affinity constant of the polystyrene for the
hCG 
Figure 5. Binding curves of log10 CPM bound versus logio
CPM added of 1-25I-hCG to polystyrene beads
and polypropylene tube. Bead 1 (0), Bead 2
(0) and polypropylene tube (A) 
26
28
Figure 6. Staphylococcal Protein A-enzyme activity
vs. concentration. Staphylococcal Protein
A-enzyme conjugate in amounts ranging from
10-1000 pg/tube were incubated with 300 pl
of OPD substrate for 30 min. The reaction
was stopped with the addition of 1 ml of
1N HCI to each tube. The delta absorbance
at 492/600 nm was determined using an
Abbott Quantum II photometer  30
Figure 7. Absorbance readings for various SPA-E and
antibody concentrations. hCG concentration
was kept constant. SPA-E concentrations
were 0.25 (*), 0.5 (0), 1.0 (4) and 2.0 (0)
pg/ml. (A) denotes beads incubated in the
absence of antibody. (II) indicates anti-
body coated beads incubated with 2.0 pg/ml





Table 1. Binding of radiolabelled hCG to poly-
styrene beads and polypropylene tube.
1251 -hCG in 0.06 M carbonate buffer,
pH 9.6, was added to 12 x 75 mm poly-
propylene tubes containing two poly-
styrene beads. Following incubation
at 37 C for 16 h the tubes were counted.
The tubes and beads were then washed
with PBS/Tween and counted separately 20
Table 2. Effect of varying the SPA-E concentration
while keeping antibody and hCG levels
fixed. Substrate used was 300 pl of OPD
incubated with bead for 30 min at room
temperature. The reaction was stopped
with 1.0 ml of 1N HC1 and the delta ab-
sorbance read on an Abbott Quantum II
analyzer  33
Table 3. Results of 3-way analysis of variance.
The independent variables were tempera-
ture (A) and concentration (B). Absor-
bance was chosen as the dependent
variable  37
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Human chorionic gonadotropin (hCG), labeled with 1251, was
used to study the binding properties of hCG to polystyrene
beads. The binding capacity of the 0.25-in diameter beads
was determined to be approximately 300 mIU/bead. The
affinity constant, K, was determined to be essentially 0,
suggesting that binding is strictly passive. The binding
of hCG to polystyrene was proportional to the hCG concentra-
tion and temperature. There were highly significant
(p<0.001) differences among amounts of hCG bound at 3 C,
25 C and 37 C. There was a highly significant (p<0.001)
relationship between the amount of hCG bound and the initial
hCG concentration. There did not appear to be any correla-
tion between the percentage of hCG bound and the initial hCG
concentration. Attempts to use Staphylococcal Protein
A-peroxidase conjugate to detect murine monoclonal anti-
bodies to beta-hCG were not successful.
viii
INTRODUCTION
Human chorionic gonadotropin (hCG) is a glycoprotein
hormone secreted by trophoblastic tissue. It is made up
of two polypeptide chains and contains 30-33% carbohydrate,
mainly sialic acid and galactose. The alpha subunits of the
four human glycoprotein hormones, luteinizing hormone, (hLH),
follicle stimulating hormone (hFSH), thyroid stimulating
hormone (hTSH), and hCG are almost identical, and the beta
subunit of hCG has a high degree of homology with the beta 
subunit of hLH.
Since hCG is normally produced by trophoblastic tissue,
its detection has long been used for the determination of
pregnancy. In normal pregnancy hCG is detectable in the
serum and urine 8-10 d after conception and reaches peak
levels during the second and third gestational month. By
exerting a luteotrophic effect, hCG maintains the developing
corpus luteum until the placenta starts to produce proges-
terone, the latter occurring approximately 8-10 wk after
conception. Kreig (1979) and Levitt and Josimovich (1976)
have reviewed the use of hCG assays in pregnancy testing as
well as in the detection and management of trophoblastic and
nontrophoblastic neoplasms. Howanitz and Howanitz (1979)
reported that adenocarcinoma of the stomach, ovary, and
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pancreas as well as hepatomas were the tumors most commonly
associated with ectopic hCG prcduction and recommended
quantitative determinations of beta-hCG for monitoring
therapy.
In a review by Lau et al. (1976), Ascheim and Zondek
were credited with developing the first recognized assay
for hCG in 1928. Ascheim and Zondek's bioassay used imma-
ture female mice and was followed by numerous other assays
which used rats, mice, rabbits and frogs. It was not
until 1968 that Wide and Gemzell introduced the first
immunological assay for hCG (Lau, 1976).
Present assays for hCG are predominantly immunological
in nature and may be divided into two major classes: (1)
agglutination or aggregation assays and (2) ligand assays
using either an enzymatic or radioactive label or detection
system. The agglutination assays for hCG involve either the
agglutination of particles coated with antibody to hCG or
the neutralization of antibody to hCG preventing antibody
binding to hCG coated particles. This type of assay, while
easy to perform, lacks sensitivity and is only semi-
quantitative.
Ligand assays may be divided into isotopic, noniso-
topic and the hybrid radioenyzmatic assays. All three
types are sensitive to low concentrations of analyte,but
this sensitivity in itself may reveal problems such as a
lack of specificity, a difficulty particularly prevalent in
receptor based assays. Other problems with ligand assays
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may be caused by using radioactive materials. The use of
radioisotopes results in short shelf life, often measured in
weeks, as well as requiring special procedures for handling
radioactive materials and wastes. Radioassays also require
the use of expensive equipment such as gamma or scintillation
spectrometers. Enzyme immunoassay techniques such as
enzyme-linked immunosorbent assay (ELISA) or enzyme multi-
plied immunometric technique (EMIT) have been proposed as
replacements for radioisotopic procedures.
This research was initiated with two objectives:
(1) to investigate the binding of hCG to polystyrene and




Human chorionic gonadotropin is a glycoprotein hormone
secreted by the Langhans' cells of the placental chorionic
villi. The biological activities of hCG and hLH are the
same, stimulating the corpus luteum to secrete progesterone
(Daughaday, 1974). There are conflicting reports as to the
role of hCG in immunosuppression. Han (1974) reported that
hCG suppressed lymphocyte response, and Schiff et al. (1975)
reported that hCG levels found in maternal serum were too
low to inhibit lymphocyte response in vitro.
Human chorionic gonadotropin levels are detectable in
the serum 8-10 d after implantation of the embryo into the
uterine wall and double every 1.4-2.1 d. The hCG levels
peak after 6-8 wk gestation with levels from 40,000 to over
200,000 mIU/ml. After peaking, hCG levels decline and then
plateau at levels of 1,000-10,000 mIU/ml. At 36-38 wk hCG
levels rise to give a second peak (Goldstein and Kasasa,
1975). Kadar et al. (1981) recommended serial determination
of hCG levels in the maternal serum to detect at-risk
pregnancies and to alert the physician to abnormalities





Human chorionic gonadotropin is composed of an alpha
subunit with a molecular weight of 13,000 and a beta subunit
with a molecular weight of 28,000. It has a high degree of
homology with the glycoprotein hormone hLH. When compared to
hLH, the alpha subunit of hCG is missing a segment of three
amino acids and has an inversion of two amino acids (Bhagavan,
1978). While 80% of the beta chain of hCG is identical to
hLH, hCG possesses 28 additional amino acids attached to the
carboxyl terminal. The beta subunit of hCG is composed of
approximately 33% carbohydrate, predominantly sialic acid
and n-acetylglucosamine (Ghai
Immunologic Properties 
Detection of low levels of hCG requires that hLH inter-
ference be eliminated. Antibodies developed against the
alpha subunit of hCG showed parallel dose-response curves
when tested using hLH (Vaitukaitis and Ross, 1972) thus show-
ing that a beta subunit specific antibody was required. Ghai
et al. (1980) showed that the carbohydrate portion of the
beta subunit of hCG was not responsible for immunological
specificity and that there were probably two types of deter-
minants present, those which were specific for the beta sub-
et al., 1980)
unit of hCG and those determinants also shared by hLH.
Panadian et al. (1980) investigated the usefulness of
several chemical modifications of the beta subunit of hCG
for developing antisera which had no cross-reactivity with
hLH. They found that during the preparation of the antigen,
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each step must be monitored in order to prevent contamination
of the antigen with concurrent loss of specificity. Attempts
to develop antisera to the unique carboxy-terminal peptide
residue of hCG have met with limited success (Louvet et al.,
1974; Matsuura et al., 1979).
Assay Design
Enzyme immunoassays (EIA) are an outgrowth of develop-
ments in a number of different fields such as enzymology,
biochemistry and immunology. Several reviews of enzyme-
immunoassay procedures and principles have been published
(Wisdom, 1976; Voller et al., 1979). Most EIA assays devel-
oped have been designed mainly by empirical means, although
several investigators have characterized some of the princi-
ples upon which the assays are based (Lethonen and Viljanen,
1980; Pain and Surolia, 1979; Cantarero et al., 1980).
Solid Phase Adsorption and Supports
Several authors have reviewed the use of solid phase
supports in immunoassay design. Leiva (1977) compared var-
ious separation techniques used in ligand assays. He con-
cluded that the mode of separation of the bound and free
complexes determined the equipment required, the speed and
sensitivity of the assay as well as the maximum number of
tests which could be performed at one time. Smith and Gehle
(1980) argued for the use of solid phases and listed some of
the support material which had been used in either EIA or RIA.
They stated that while a finely ground solid phase had more
surface area, the separation time required supported the use
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of a single-piece solid phase.
Cantarero et al. (1980) showed that the binding of
proteins to polystyrene was dependent on a number of factors
such as surface area, concentration of the protein and its
proportion to the total protein level, time and temperature.
Ionic charge did not appear to play a role in protein/poly-
styrene binding, and the upper limit of protein binding was
correlated to the surface area and the Stokes radii of the
protein--the upper limit being a layer of protein one mole-
cule thick.
Types of Assays
Ekins (1981) discussed the advantages and disadvantages
of several types of immunoassays and labeling systems and
divided the assays into two main groups. Type I assays are
thcEe procedures in which there is excess antibody present,
and Type II assays are those in which there is excess
analyte.
Type I assays are based on the binding of analyte to a
large excess of antibody followed by detection of the bound
analyte. Practical applications of this technique have been
in the form of sandwich assays using either radio-labeled
(Shimizu et al., 1982; Wang et al., 1981) or enzyme-labeled
antibody (Voller et al., 1976). The theoretical sensitivity
of this type of assay approaches one molecule as the antibody
concentration reaches infinity. While highly purified anti-
gen is not required for Type I assays, nonspecific binding
interactions between antibodies and steric inhibition
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requires that the antibodies have high affinity and
specificity.
Type II assays are generally based on competition be-
tween labeled and unlabeled analyte for a limited number of
binding sites. Classical radioimmunoassay procedures are
examples of this form of assay (Yalow and Berson, 1971). In
Type II assays, the antibody used must have the same affinity
for both the labeled and unlabeled antigen, the labeled anti-
gen must not be contaminated with potentially cross-reacting
compounds, and the reaction conditions must be carefully con-
trolled (Bolton, 1981). The sensitivity of Type II assays is
determined by the minimum detectable signal from the labeled
antigen and the affinity constant of the antibody used. As
antibody concentration approaches zero, Type II assay sensi-
tivity reaches its maximum.
Elkins (1981) concluded that Type I assays are capable
of detecting much lower levels of analyte than Type II
assays. The Type II assays are, however, less susceptible to
cross-reacting antigens.
Yorde et al. (1976) introduced a new method for immuno-
assay, CELIA, or competitive enzyme-linked immunoassay.
CELIA involves competition between a solid-phase antigen and
soluble antigen for a fixed number of antibody binding sites.
The amount of antibody bound to the solid phase antigen is
then quantitated and a binding curve inversely proportional
to the free antigen concentration is developed. This type
of assay used a variation of the Type II assay substituting
the bound antigen for the labeled analyte and detected the
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immobilized antibody through Type I (saturation) techniques.
Yorde et al. (1976) demonstrated the principles of CELIA in
an assay for hCG which had a sensitivity of 1,000 mIU/m1 and
was not specific for the beta subunit. The assay used hCG
covalently linked to Sepharose particles and three different
antibodies.
Tomoda et al. (1980) developed a sequential solid-phase
assay for hCG using antibody coated silicone rods and hCG
labeled with beta-D-galactosidase from Escherichia coli in a
modified Type II assay. This assay was sensitive to 0.5
mIU/m1 but not specific for beta-hCG. Another Type II assay
for hCG was that of Joshi et al. (1981) in which the enzyme
used was penicillinase conjugated to hCG. Joshi's assay had
a range of 200-1000 mIU/ml, but again was not specific for the
beta subunit of hCG.
Enzyme-Antibody Conjugates
Schick and Singer (1961) reported the coupling of
ferritin and antibody and the use of this conjugate in
electron microscopy. Avrameas (1969) used gluteraldehyde to
couple the enzyme peroxidase to antibody for use in immuno-
histochemistry. Since that time a number of different en-
zymes and techniques have been used (Avrameas et al., 1978).
Staphylococcal Protein A
Staphylococcal Protein A (SPA) is a 42,000-molecular
weight lectin found in the cell wall of certain strains of
Staphylococcus aureus. SPA has a high affinity for the Fc
portion of mammalian IgG molecules and has been used in a
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number of assays to detect antibody (Langone, 1978; Lang
one,
1980; Engvall, 1979; Notani et al., 1979; Pain and Surolia,
1979). Langone (1978) reported that SPA had a very high
affinity for antibodies from rabbits, humans and guinea pig
s,
but showed only one-thousandth the affinity for mouse IgG.
Monoclonal Antibodies 
One of the major problems in the area of immunoassays
has been the inability to produce consistently high-titer
antibodies with suitable specificity in reasonable quantiti
es
for commercial use. Antisera produced by conventional m
eans
are heterogenous in nature, consisting of many antibodie
s of
differing affinities and specificities. Attempts to improv
e
antisera specificity by using highly purified antigens a
nd
various immunization techniques have been made. Such me
thods,
combined with affinity chromatography techniques have im
-
proved specificity to some degree; however, the quality 
of
the antisera produced is still subject to the idiosync
rasies
of the individual animal used.
Kohler and Milstein (1975) developed a technique for
the production and continous culture of antibody-secreti
ng
cells which the authors referred to as hybridomas. A hybri
-
doma is produced by the fusion of an antibody-producing
mouse spleen cell and a plasmacytoma cell forming an
immortal antibody-producing cell line. Since a single B
lymphocyte will produce antibody to only one antigenic
determinant, the ability to grow large quantities of a




pure antibody of easily definable affinity and specificity.
By conducting a properly designed screening procedure, it is
possible to produce highly specific antibodies to antigenic
determinants using very impure antigens such as crude cell
preparations (Brown et al., 1981).
MATERIALS AND METHODS
Chemicals
Antibody to beta-hCG was obtained from Miles Scientific,
Division of Miles Laboratories (stock number 63-104). Tween
20, Staphylococcal Protein A-Peroxidase conjugate, and
Sigmacote were obtained from Sigma Chemical Company.
125I-1iCG was specially prepared without additional protein by
Cambridge Radionuclear Incorporated. Alkaline Phosphatase
anti-beta-hCG antibody was a gift of Hybritech Incorporated
and hCG (Pregnyl) was purchased from Organon Pharmaceutical.
Polystyrene beads and ortho-phenylenediamine (OPD) substrate
were obtained from Abbott Laboratories.
All buffers were prepared with reagent grade chemicals
and the pH determined using an Orion 601A analyser.
Proposed Method
The proposed assay for hCG was a modified version of
Yorde et al. (1976). The modifications consisted of the use
of a 0.25-in diameter polystyrene bead for the solid phase
and the detection of the bound antibody through the use of
enzyme-labeled Staphylococcal Protein A.
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Adsorption of hCG to Polystyrene Beads 
All glassware was siliconized to minimize protein
absorption to glass. This was accomplished by coating all
internal surfaces of vessels with Sigmacote for approxi-
mately 45 sec, draining, and allowing tc air-dry in an
inverted position overnight. Efficacy of treatment was
checked by observing the nonwetting properties of the coated
tubes using water.
Stock hCG was reconstituted with supplied buffer to a
concentration of 1,000,000 mIU/ml. One milliliter of stock
hCG was then diluted to a working concentration of 1,000
mIU/ml in 0.06 M carbonate buffer, pH 9.6. Dilutions of the
working hCG were made to give concentrations of 100, 200, 400,
600, 800 and 1,000 mIU/ml. Three-milliliter aliquots of the
diluted hCG solutions were placed into three sets of six test
tubes (12 x 75 mm). After addition of three polystyrene
beads to each tube, one set each was incubated at 3 C, 25 C,
and 37 C for 16 h.
After incubation, the beads were thrice washed with 5-ml
aliquots of phosphate buffered saline with Tween 20
(PBS/Tween) using a multiwell washing assembly (Pentawash-
Abbott). PBS/Tween was made up of 0.9 g of NaC1, 2.0 g of
KH2PO4, 2.9 g of Na2HPO4:12H20, 0.2 g of KCI, and 0.5 ml of
Tween 20 per liter of distilled water.
After washing, the beads were placed into trays and
incubated with alkaline phosphatase anti-beta-hCG conjugate
(diluted 1:20 with PBS/Tween) for 90 min at 37 C. The
beads were again washed with PBS/Tween and transferred to
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12 x 75 mm cuvettes. Two-tenths milliliter of p-nitrophenol
phosphate substrate was added to each tube and allowed to
incubate for 15 min at room temperature. The addition of
2.0 ml of quenching reagent (0.2M EDTA) stopped the reaction
and the absorbance of the solutions was determined using a
Perkin Elmer Jr II Model 6/20 spectrophotometer.
Quantitative Characterization of Binding
One microcurie of 125I-hCG (SA=169 pCiAug) was added to
1,000 mIU of hCG to give a specific activity of 1000 mIU/pCi/-
ml. Serial dilutions of the stock radiolabeled hCG were then
made to give concentrations ranging from 0.98-250 mIU.
Aliquots of 0.5 ml were then added to labeled 12 x 75 mm
polypropylene tubes and two polystyrene beads were added to
each tube. Following incubation at 37 C overnight, the beads
were then washed with PBS/Tween and counted for 1 min in a
Packard 5110 gamma counter with the window set for 1251. The
counter had an efficiency of 61%.
One microcurie was added to 16,500 mIU of hCG to give a
specific activity of 16,500 mIU/pCi/ml. Serial dilutions of
the labeled hCG were made in the range of 2-412.5 mIU/m1
using carbonate buffer. One bead was placed into each tube
and incubated overnight at 37 C. The beads were then washed
as previously described and counted. The activity bound to
the bead was then corrected for decay and counter efficiency
and converted to hCG concentration.
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Staphylococcal Protein A-Enzyme Conjugate
Staphylococcal Protein A-Enzyme conjugate (SPA-E) was
reconstituted with 50% PBS/Tween and glycerol to a concentra-
tion of 250 pg/ml. Dilutions of the SPA-E stock were made in
PBS/Tween to give concentrations ranging from 2.0 pg/m1-2.0
pg/ml. One hundred-microliter aliquots of the SPA-E dilutions
were pipetted into cuvettes and 300 pl of OPD substrate added.
OPD substrate was made up of 40 mg of OPD-2HC1 in 100 ml of
0.2 M phosphate-citrate buffer, pH 5.0, and 40 pl of
30% v/v H202. After 30 min incubation at room temperature in
the dark, the reaction was stopped with the addition of 1.0 ml
of 1N HC1 to all tubes. The delta absorbance at 492/600 nm
was determined using an Abbott Quantum II analyser.
To determine the working concentration of SPA-E required
to detect maximum binding of antibody, hCG coated beads were
incubated with an excess of mouse anti-beta-hCG antibody for
60 min at 37 C. The beads were then washed three times and
200 Ail of the SPA-E conjugate dilutions were added. After 60
min incubation at 37 C, the unbound SPA-E was washed off and
the enzyme activity bound was determined by incubating the
beads with 300 All of OPD substrate as outlined above.
Statistical Analysis
To determine whether or not hCG binding was dependent on
temperature or concentration, statistical analyses were per-
formed on the resulting data. Pearson's product-moment
correlation, linear regression, and 3-way analysis of variance
were carried out. Analysis of binding properties was done in
accordance with principles set forth by Adrion (1982), Walker
RESULTS
Temperature and Concentration Effects on Binding
The effects of temperature and concentration on the
binding of hCG to the polystyrene beads are shown in Fig 1.
Each absorbance value represents the average of three beads.
Human chorionic gonadotropin binding increased with increas-
ing temperature and concentration reaching a peak at approx-
imately 600 MIU/ml. Maximum binding occurred at 37 C, and
this temperature was chosen for the remaining studies.




the hCG demonstrated that the percentage of hCG binding
polypropylene tubes. A significant amount of
adsorbed to the polypropylene tubes are illus-
Calculation of the percent-recovery of
was
not related to concentration. Figure 2 depicts percent-bind-
ing versus initial concentration.
The binding studies were repeated using siliconized
glass tubes and hCG with known specific activity. Calculation
of hCG bound was accomplished by correcting for the counter
efficiency and isotope decay. Figure 3 is a graph of mIU of
hCG recovered versus hCG added.
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Figure 1 Effects of temperature and concentration on the
absorption of hCG to polystyrene beads. Alkaline
phosphatase anti-beta-hCG conjugated antibody was
used to detect bound nCG. The substrate used was
p-nitrophenol phosphate. The reaction was stopped
by the addition of 2.0 ml of 0.2M EDTA and
absorbance readings were made at 405 nm. Each
point represents the average of 3 absorbance
values. Incubation temperatures were 3 C (A),
25 C (0) and 37 C (0).
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Table 1. Binding of radiolabeled hCG to polystyrene beads
and polypropylene tube. 1251-hCG in 0.06 M
carbonate buffer, pH 9.6, was added to 12 x 75
mm polypropylene tubes containing two polystyrene
beads. Following incubation at 37 C for 16 h
the tubes were counted. The tubes and beads were
then washed with PBS/Tween and counted separately.
hCG CPM1 Bead Bead Tube
bead added 1 2
0.00 84 86 91 86
0.49 1550 240 253 256
0.98 3017 384 358 482
1.95 5668 653 517 988
3.91 11670 1386 1087 2184
7.81 23233 2857 3500 3141
15.62 46534 6196 7000 4404
31.25 91532 9833 10626 6318
62.50 176224 11844 11963 9106
125.00 350568 12944 15120 13023
All cpm are raw counts
hCG/bead denotes approximate mIU of hCG added per
bead.
cpm added are total counts per minute initially added to
tubes.
Bead 1 and 2 are duplicates.
Tube denotes cpm bound to the polypropylene tube used in
incubation.
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Figure 2. Percentage of hCG bound to polystyrene beads as a
function of initial concentration. Several runs
are shown. (0) represent initial concentrations
of 2-412 mIU/m1 hCG. (0) are beads which were







1 . 0 10.0 100.0
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500.0
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Figure 3. Binding linearity as a function of initial hCG
concentration. Exclusion of the outlying point
gives the regression line shown. mIU hCG bound
was equal to 0.327 (mIU hCG added), r=0.997.
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Derivation of Binding Capacity and Affinity Constant
The derivation of the binding capacity (Ab) and the
affinity constant (K) of polystyrene for hCG was done
according to the methods set forth by Walker (1977). By
plotting counts bound against labeled ligand, the curve
shown in Fig 4 was generated. Two assumptions must be made:
(J) the amount of ligand bound cannot exceed the amount of
ligand added and (2) an upper limit of binding is set by
saturation of all of the binding sites. By determining the
slope of the line, the level of maximum binding and the 50%
binding concentration, Ab and K may be calculated. Binding
capacity (Ab) is equal to the cpm bound at the plateau
(Ab=1.0),and the slope is a line drawn tangent to the curve
at the point where binding (B) is G. Li is equal to the
amount of hCG added at the point where the slope crosses Ab
(point X in Fig 4), L2 being the hCG concentration at the
level of 0.5 Ab. Ab and K may be determined through the
equations
Li = 1/K + Ab
L2 = 1/K + 0.5 Ab
Thus, 1/K = 2(L2) Li and Ab = 2(L1) - 2(L2).
Fig 5 is a plot of the data in Table 1 but has not been
corrected for differences in surface area.
Staphylococcal Protein A Conjugate
Fig 6 is a graph of the delta absorbance of 492/600
26
Figure 4. Derivation of K and Ab. OX is the slope tangent
to the curve at 0 mIU binding. (--) denotes the
plateau or maximum binding. Ab refers to the
total binding capacity of the bead. Curve is
actual binding data. If Ll is defined as the hCG
concentration where the line OX crosses Ab and
the point at which OX crosses 0.5 Ab as L2, then
K may be determined as 1/(2(L2)-L1) and Ab may be
calculated, Ab=2(L1)-2(L2). K is the affinity



















































































































































































Figure 6. Staphylococcal Protein A-enzyme activity vs.
concentration. Staphylococcal Protein A-enzyme
conjugate in amounts ranging from 10-1000 pg/-
tube were incubated with 300 pl of OPD sub-
strate for 30 min. The reaction was stopped
with the addition of 1 ml of 1N HC1 to each
tube. The delta absorbance at 492/600 nm was
determined using an Abbott Quantum II photometer.
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nm versus SPA-E concentration. It was determined that a
minimum of 150 pg of SPA-E was required to be bound to the
solid-phase hCG-antibody complex in order to give an adequate
assay range. Table 2 indicates the results of incubating
SPA-E conjugate in concentrations of 0.05, 0.5, and 1.0 pg/m1
with antibody-saturated beads. Absorbance values ranged
from 0.121 to 0.684. Further studies were carried out by
varying both the antibody and the SPA-E concentration in a
"checker board" titration, the results of which are shown
in Fig 7. The addition of 100 pl of 0.1% bovine serum
albumin to block nonspecific binding virtually eliminated
enzyme activity (Fig 7).
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Table 2. Effect of varying the SPA-E concentration while
keeping antibody and hCG levels fixed. Substrate
used was 300 pl of OPD incubated with bead for 30
min at room temperature. The reaction was stopped
with 1.0 ml of 1N HC1 and the delta absorbance read
on an Abbott Quantum II analyser.








SPA-E- Staphylococcal Protein A-Enzyme
conjugate;
Abs 492/600- The difference in the absorb-
ance of the reaction mixture at 492
nm and 600 nm.
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Figure 7. Absorbance readings for various SPA-E and antibody
concentrations. hCG concentration was kept con-
stant. SPA-E concentrations were 0.25 (0), 0.5
(0), 1.0 (A) and 2.0 (0) pg/ml. (a) denotes
beads incubated with SPA-E in the absence of
antibody. (M) indicates antibody coated beads
incubated with 2.0 jig/ml SPA-E and 100 pl of




The results of the temperature studies (Fig 1 and
Table 3) indicated that the binding of hCG to polystyrene
was both temperature and concentration dependent. The split
plot analysis of variance showed that there were significant
differences in the absorbance readings between temperature
and concentration, between temperature and binding, and be-
tween concentration and binding. The decreased absorbance
level seen at 800 mIU/m1 in Fig I cannot be easily explained.
Possible explanations such as insufficient antibody con-
jugate being present to saturate all of the hCG binding
sites may be ruled out because of the much higher absorbance
levels seen at 1000 mIU/ml. Steric inhibition of binding by
the antibody does not appear to be the cause of the decreased
readings. The decreases in absorbance should have reached
the same level since the inhibition occurred at the same
concentration of hCG.
Linear regression studies of the radiolabeled hCG
binding studies again showed that there was a significant
correlation between the amount of hCG bound and the initial
concentration. Regression analysis of the percent hCG bound
to the initial concentration was non-significant.
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Table 3. Results of 3-way analysis of variance. The
independent variables were temperature (A) and
concentration (B). Absorbance was chosen as the
dependent variable.
Source df p(F)
Between Temperatures 2 .001
Between Concentrations 8 .001
Between Temperature and 24 .001
Concentration
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The findings that temperature and initial concentration
play significant roles in the binding of hCG to polystyrene
and that the percentage of binding is independent of concen-
tration are in agreement with studies on other proteins
(Cantarero et al., 1980).
The affinity constant, K, was calculated to be
essentially 0, (-0.5 L/IU, and indicated that the binding
was probably entirely passive. The binding capacity, Ab,
was determined to be 300 mIU/bead. Cantarero et al. (1980)
reported an upper limit of approximately 1000 ng of protein
was bound to 6.5 cm2 of polystyrene. If the value of 1
ng/mIU hCG (Langone, 1980) is used, a maximum protein binding
capacity of approximately 195 ng/bead was determined after
correcting for the difference in surface area of the 0.25-in
diameter polystyrene beads. Accounting for the beads
increased surface area due to specularization and
experimental error, the actual and calculated values are
in relative agreement.
By knowing the binding capacity of a specific protein
and lot number of polystyrene, assay design could be
simplified and discrepancies in protein concentrations could
be resolved. Knowing the amount of protein which could
be bound to a solid-phase allows the calculation of the
minimum amount of support material which could be used in a
specific assay (Adrion (1982); and Halfman (1979)). By
determining the minimum amount of signal which is acceptable
for a particular assay, the minimum amount of surface
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required for a given sample and assay volume may be determined
through Adrion's methods. The optimum assay parameters may be
derived from Halfman's analyses.
The failure of the Staphylococcal Protein A conjugate to
bind to the monoclonal mouse IgG may be due to several rea-
sons: (1) the low affinity of SPA for murine IgG as reported
by Langone (1980), (2) the murine antibody is of a subclass
for which SPA has no affinity, and (3) the all or none charac
teristics of monoclonal antibodies. If, by definition, a
monoclonal antibody is specific for only one antigenic deter-
minant, there will in all probability be only one antibody
molecule binding to the antigen. The likelyhood of multiple
identical binding sites on a protein is improbable. Thus,
because of monovalency, the amount of antibody bound is
greatly decreased when compared to conventional polyvalent
antisera. Increasing the detection limits of the SPA-E con-
jugate, either through the use of chemiluminescent or flouri-
metric techniques, may compensate for the apparent lack of
SPA-murine IgG interaction if the problem is due to low
affinity; otherwise, antisera from other sources will be re-
quired. Pain and Surolia (1979) and Langone (1978) developed
assays for hCG using SPA as an indicating system; however,
both used rabbit antisera.
SUMMARY
1. The binding of hCG to polystyrene beads was
temperature and concentration dependent. Increasing either
the incubation temperature or the initial concentration of
hCG increased the amount of hCG bound to the polystyrene
bead.
2. The percentage of hCG bound to polystyrene was
independent of the hCG concentration.
3. The affinity constant, K, of polystyrene for hCG
was essentially 0 and signified that the protein-polymer
interaction was probably passive.
4. The binding capacity, Ab, of the polystyrene beads
used was 300 mIU of hCG/bead. This value was in agreement
with published reports for other proteins.
5. If monoclonal antibodies are to be employed in an
assay then consideration should be given to the applicability
of the indicator system proposed.
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